- Current report filing (8-K)
14 September 2012 - 4:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event
reported): September 14, 2012 (September 10, 2012)
CardioGenics Holdings Inc.
(Exact Name of Registrant as Specified in
its Charter)
Nevada
|
000-28761
|
88-0380546
|
|
|
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification)
|
6295 Northam Drive, Unit 8, Mississauga,
Ontario, L4V 1W8
(Address of Principal Executive Offices)(Zip
Code)
Registrant’s telephone number, including
area code: 905.673.8501
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction
A.2. below):
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
|
Item 5.03 Amendments to Articles of Incorporation or By-Laws; Change in Fiscal Year
|
|
Item 9.01 Financial Statements and Exhibits
|
|
SIGNATURE
|
|
Item 5.03 – Amendments to Articles
of Incorporation or By-Laws; Change in Fiscal Year
On September 10, 2012, our Board of Directors
(the “
Board
”) amended Article I, Section .01 of our By-Laws to provide the Board with full discretion to set
the date of our Annual Meeting.
The foregoing description is qualified
in its entirety by reference to the amendment approved by the Board as contained in the Amendment to By-Laws of CardioGenics Holdings
Inc., effective September 10, 2012, a copy of which is attached hereto and incorporated herein as Exhibit 3.1 to this Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
3.1
|
Amendment to By-Laws of CardioGenics Holdings Inc. dated September 10, 2012
|
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
CARDIOGENICS HOLDINGS INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Yahia Gawad
|
|
|
Name: Yahia Gawad
|
|
|
Title: Chief Executive Officer
|
Dated: September 14, 2012
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
Von Jul 2023 bis Jul 2024